Weight & Metabolic Research Peptides
Reference standards for incretin and metabolic-pathway research, including the GLP-1 receptor agonist semaglutide, the dual GIP/GLP-1 agonist tirzepatide, and the triple-agonist retatrutide — alongside cagrilintide, AOD-9604, MOTS-c, tesamorelin, and 5-Amino-1MQ. These compounds are widely studied in appetite-regulation, energy-expenditure, and insulin-signaling models.
Every lot is supplied lyophilized in multi-vial research kits and ships from our US facility within 48 hours with tracking. For in-vitro laboratory research and analytical method development only — not for human or veterinary use.
GLP-1 receptor agonist studied in appetite-regulation, caloric-intake and metabolic research models.
Dual GIP/GLP-1 receptor agonist studied in appetite-regulation, insulin-signaling and metabolic research models.
Triple GLP-1/GIP/glucagon receptor agonist under active study in metabolic and energy-expenditure research models.
Modified HGH fragment (176-191) studied in lipolysis and fat-metabolism research models without IGF-1 signaling.
Small-molecule NNMT inhibitor studied in adipocyte, NAD+ salvage and metabolic research models.
Amylin/GLP-1 combination studied in appetite-regulation and metabolic research models.
Mitochondrial-derived peptide studied for metabolic regulation, insulin sensitivity, and exercise adaptation.
GHRH analog studied in growth-hormone pulse and visceral-adiposity research models.